• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PSGL-1是一种促进T细胞耗竭的免疫检查点调节因子。

PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.

作者信息

Tinoco Roberto, Carrette Florent, Barraza Monique L, Otero Dennis C, Magaña Jonathan, Bosenberg Marcus W, Swain Susan L, Bradley Linda M

机构信息

Infectious and Inflammatory Disease Center and NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Research Institute, La Jolla, CA 92037, USA; Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA.

Infectious and Inflammatory Disease Center and NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Research Institute, La Jolla, CA 92037, USA.

出版信息

Immunity. 2016 May 17;44(5):1190-203. doi: 10.1016/j.immuni.2016.04.015.

DOI:10.1016/j.immuni.2016.04.015
PMID:27192578
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4908967/
Abstract

Chronic viruses and cancers thwart immune responses in humans by inducing T cell dysfunction. Using a murine chronic virus that models human infections, we investigated the function of the adhesion molecule, P-selectin glycoprotein ligand-1 (PSGL-1), that is upregulated on responding T cells. PSGL-1-deficient mice cleared the virus due to increased intrinsic survival of multifunctional effector T cells that had downregulated PD-1 as well as other inhibitory receptors. Notably, this response resulted in CD4(+)-T-cell-dependent immunopathology. Mechanistically, PSGL-1 ligation on exhausted CD8(+) T cells inhibited T cell receptor (TCR) and interleukin-2 (IL-2) signaling and upregulated PD-1, leading to diminished survival with TCR stimulation. In models of melanoma cancer in which T cell dysfunction occurs, PSGL-1 deficiency led to PD-1 downregulation, improved T cell responses, and tumor control. Thus, PSGL-1 plays a fundamental role in balancing viral control and immunopathology and also functions to regulate T cell responses in the tumor microenvironment.

摘要

慢性病毒和癌症通过诱导T细胞功能障碍来阻碍人类的免疫反应。我们使用一种模拟人类感染的小鼠慢性病毒,研究了在反应性T细胞上上调的粘附分子P-选择素糖蛋白配体-1(PSGL-1)的功能。PSGL-1缺陷小鼠清除了病毒,这是由于多功能效应T细胞的内在存活率增加,这些T细胞下调了PD-1以及其他抑制性受体。值得注意的是,这种反应导致了CD4(+) T细胞依赖性免疫病理学。从机制上讲,耗尽的CD8(+) T细胞上的PSGL-1连接抑制了T细胞受体(TCR)和白细胞介素-2(IL-2)信号传导,并上调了PD-1,导致TCR刺激下存活率降低。在发生T细胞功能障碍的黑色素瘤癌症模型中,PSGL-1缺陷导致PD-1下调、T细胞反应改善和肿瘤控制。因此,PSGL-1在平衡病毒控制和免疫病理学方面发挥着重要作用,并且在肿瘤微环境中也起到调节T细胞反应的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ff/4908967/1fd31cbca0fe/nihms785008f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ff/4908967/71e1ec56cefa/nihms785008f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ff/4908967/bd33514f74fc/nihms785008f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ff/4908967/3312f5521c5e/nihms785008f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ff/4908967/bf16dec9414c/nihms785008f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ff/4908967/dc0fd62eab27/nihms785008f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ff/4908967/a12b4b43a8f9/nihms785008f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ff/4908967/1fd31cbca0fe/nihms785008f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ff/4908967/71e1ec56cefa/nihms785008f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ff/4908967/bd33514f74fc/nihms785008f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ff/4908967/3312f5521c5e/nihms785008f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ff/4908967/bf16dec9414c/nihms785008f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ff/4908967/dc0fd62eab27/nihms785008f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ff/4908967/a12b4b43a8f9/nihms785008f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ff/4908967/1fd31cbca0fe/nihms785008f7.jpg

相似文献

1
PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.PSGL-1是一种促进T细胞耗竭的免疫检查点调节因子。
Immunity. 2016 May 17;44(5):1190-203. doi: 10.1016/j.immuni.2016.04.015.
2
Contrasting roles of PSGL-1 and PD-1 in regulating T-cell exhaustion and function during chronic viral infection.PSGL-1和PD-1在慢性病毒感染期间调节T细胞耗竭和功能中的相反作用。
J Virol. 2025 Mar 18;99(3):e0224224. doi: 10.1128/jvi.02242-24. Epub 2025 Feb 6.
3
PSGL-1 Is a T Cell Intrinsic Inhibitor That Regulates Effector and Memory Differentiation and Responses During Viral Infection.PSGL-1 是一种 T 细胞内源性抑制剂,可调节病毒感染期间效应细胞和记忆细胞的分化和应答。
Front Immunol. 2021 Jul 13;12:677824. doi: 10.3389/fimmu.2021.677824. eCollection 2021.
4
PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells.PD-1 免疫检查点阻断和 PSGL-1 抑制协同作用,重新激活衰竭的 T 细胞。
Front Immunol. 2022 Jun 14;13:869768. doi: 10.3389/fimmu.2022.869768. eCollection 2022.
5
PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.PD-L1 检查点抑制缩小了慢性淋巴细胞脉络丛脑膜炎病毒感染中抗原特异性 T 细胞受体库。
J Virol. 2020 Aug 31;94(18). doi: 10.1128/JVI.00795-20.
6
Transcription Factor IRF4 Promotes CD8 T Cell Exhaustion and Limits the Development of Memory-like T Cells during Chronic Infection.转录因子 IRF4 促进慢性感染期间 CD8 T 细胞耗竭并限制记忆样 T 细胞的发育。
Immunity. 2017 Dec 19;47(6):1129-1141.e5. doi: 10.1016/j.immuni.2017.11.021. Epub 2017 Dec 12.
7
Polymicrobial Sepsis Increases Susceptibility to Chronic Viral Infection and Exacerbates CD8+ T Cell Exhaustion.多微生物败血症增加对慢性病毒感染的易感性并加剧CD8 + T细胞耗竭。
J Immunol. 2015 Jul 1;195(1):116-25. doi: 10.4049/jimmunol.1402473. Epub 2015 May 15.
8
Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.慢性病毒感染过程中 Tim-3 和 PD-1 在 CD8 T 细胞耗竭中的协同作用。
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14733-8. doi: 10.1073/pnas.1009731107. Epub 2010 Aug 2.
9
PSGL-1 regulates the migration and proliferation of CD8(+) T cells under homeostatic conditions.PSGL-1 调节稳态条件下 CD8(+) T 细胞的迁移和增殖。
J Immunol. 2012 Feb 15;188(4):1638-46. doi: 10.4049/jimmunol.1103026. Epub 2012 Jan 16.
10
Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection.慢性淋巴细胞性脉络丛脑膜炎病毒(LCMV)感染期间,调节性T细胞与程序性死亡受体1(PD-1)在调节T细胞耗竭和病毒控制中的相互作用。
J Exp Med. 2014 Aug 25;211(9):1905-18. doi: 10.1084/jem.20132577. Epub 2014 Aug 11.

引用本文的文献

1
When the victim becomes the villain: Platelets as drivers of immune dysregulation in ITP.当受害者变成反派:血小板作为免疫性血小板减少症中免疫失调的驱动因素
J Transl Autoimmun. 2025 Aug 19;11:100309. doi: 10.1016/j.jtauto.2025.100309. eCollection 2025 Dec.
2
A genome-wide association study integrated with single-cell and bulk profiles uncovers susceptibility genes for nasopharyngeal carcinoma involved in tumorigenesis via regulation of T cells.一项整合单细胞和整体图谱的全基因组关联研究揭示了通过调节T细胞参与鼻咽癌肿瘤发生的易感基因。
Genome Biol. 2025 Jul 7;26(1):195. doi: 10.1186/s13059-025-03657-9.
3
Beyond the tumor microenvironment: Orchestrating systemic T‑cell response for next‑generation cancer immunotherapy (Review).

本文引用的文献

1
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.纳武利尤单抗与伊匹木单抗联合用药或单药治疗初治黑色素瘤
N Engl J Med. 2015 Jul 2;373(1):23-34. doi: 10.1056/NEJMoa1504030. Epub 2015 May 31.
2
The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cells.转录因子NFAT会促进活化的CD8⁺ T细胞耗竭。
Immunity. 2015 Feb 17;42(2):265-278. doi: 10.1016/j.immuni.2015.01.006. Epub 2015 Feb 10.
3
Innate and adaptive immune cells in the tumor microenvironment.肿瘤微环境中的固有和适应性免疫细胞。
超越肿瘤微环境:为下一代癌症免疫疗法协调全身T细胞反应(综述)
Int J Oncol. 2025 Jul;67(1). doi: 10.3892/ijo.2025.5762. Epub 2025 Jun 13.
4
Comprehensive analysis of SELPLG as a potential immunotherapy target and prognostic biomarker in oncology.对SELPLG作为肿瘤学中潜在免疫治疗靶点和预后生物标志物的综合分析。
Discov Oncol. 2025 Jun 12;16(1):1073. doi: 10.1007/s12672-025-02934-0.
5
Targeting tumor metabolism to augment CD8 T cell anti-tumor immunity.靶向肿瘤代谢以增强CD8 T细胞抗肿瘤免疫力。
J Pharm Anal. 2025 May;15(5):101150. doi: 10.1016/j.jpha.2024.101150. Epub 2024 Nov 20.
6
Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressure.剖析小儿高级别胶质瘤的免疫格局揭示了治疗压力下的细胞状态变化。
Cell Rep Med. 2025 May 20;6(5):102095. doi: 10.1016/j.xcrm.2025.102095. Epub 2025 May 1.
7
Contrasting roles of PSGL-1 and PD-1 in regulating T-cell exhaustion and function during chronic viral infection.PSGL-1和PD-1在慢性病毒感染期间调节T细胞耗竭和功能中的相反作用。
J Virol. 2025 Mar 18;99(3):e0224224. doi: 10.1128/jvi.02242-24. Epub 2025 Feb 6.
8
Myeloid cells meet CD8 T cell exhaustion in cancer: What, why and how.髓系细胞与癌症中的CD8 T细胞耗竭:是什么、为什么以及如何发生。
Chin J Cancer Res. 2024 Dec 30;36(6):616-651. doi: 10.21147/j.issn.1000-9604.2024.06.04.
9
A pair of promising immune checkpoints PSGL-1 and VISTA from immunotolerance to immunotherapy.一对从免疫耐受到免疫治疗的有前景的免疫检查点PSGL-1和VISTA。
Biomark Res. 2024 Dec 2;12(1):151. doi: 10.1186/s40364-024-00693-8.
10
VISTA-mediated immune evasion in cancer.癌症中VISTA介导的免疫逃逸。
Exp Mol Med. 2024 Nov;56(11):2348-2356. doi: 10.1038/s12276-024-01336-6. Epub 2024 Nov 1.
Nat Immunol. 2013 Oct;14(10):1014-22. doi: 10.1038/ni.2703.
4
Nivolumab plus ipilimumab in advanced melanoma.纳武利尤单抗联合伊匹单抗治疗晚期黑色素瘤。
N Engl J Med. 2013 Jul 11;369(2):122-33. doi: 10.1056/NEJMoa1302369. Epub 2013 Jun 2.
5
PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells.PD-L1 阻断与 IL-2 治疗协同作用,重新激活衰竭的 T 细胞。
J Clin Invest. 2013 Jun;123(6):2604-15. doi: 10.1172/JCI67008. Epub 2013 May 15.
6
PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis.PD-1 通过诱导抗病毒 T 细胞运动麻痹促进免疫衰竭。
J Exp Med. 2013 Apr 8;210(4):757-74. doi: 10.1084/jem.20121416. Epub 2013 Mar 25.
7
Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice.程序性细胞死亡蛋白 1 可防止小鼠全身性病毒感染导致的致命性循环衰竭。
J Exp Med. 2012 Dec 17;209(13):2485-99. doi: 10.1084/jem.20121015. Epub 2012 Dec 10.
8
Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection.CD8+ T 细胞的祖细胞和终末细胞亚群共同协作以控制慢性病毒感染。
Science. 2012 Nov 30;338(6111):1220-5. doi: 10.1126/science.1229620.
9
FOXO3 regulates the CD8 T cell response to a chronic viral infection.FOXO3 调节 CD8 T 细胞对慢性病毒感染的反应。
J Virol. 2012 Sep;86(17):9025-34. doi: 10.1128/JVI.00942-12. Epub 2012 Jun 6.
10
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.抗 PD-1 抗体在癌症中的安全性、活性和免疫相关性。
N Engl J Med. 2012 Jun 28;366(26):2443-54. doi: 10.1056/NEJMoa1200690. Epub 2012 Jun 2.